Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems

by Han N, Oh JM, Kim IW
Published 2021-08-01

Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference

by Kim MG, Ko M, Kim IW, Oh JM
Published 2016-11-01

Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review

by Jeong S, Kim JH, Kim MG, Han N, Kim IW, Kim T, Oh JM
Published 2016-02-01

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients

by Jeong S, Kim IW, Oh KH, Han N, Joo KW, Kim HJ, Oh JM
Published 2016-07-01

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation

by Han N, Han SH, Song YK, Kim MG, Kim YS, Kim IW, Oh JM
Published 2017-11-01

Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial

by Han N, Hong SH, Kim YS, Kim DK, Kim IW, Ji E, Oh JM
Published 2017-08-01

Impact of depression on change in coronary heart disease risk status: the Korean Genome and Epidemiology Study (KoGES)

by Jang HY, Song YK, Kim JH, Kim MG, Han N, Lee HY, Kim IW, Oh JM
Published 2018-01-01